Treatment of Huntington's Disease by Inhibition of Caspase-6 Cleavage Using CRISPR Base Editing

被引：0
|
作者：
Shirguppe, Shraddha [1 ]
机构：
[1] UIUC, Dept Bioengn, Urbana, IL USA
来源：
MOLECULAR THERAPY | 2023年 / 31卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
1562
引用
收藏
页码：734 / 734
页数：1
相关论文
共 50 条
  • [31] Caspase-6 Knockout in the 5xFAD Model of Alzheimer's Disease Reveals Favorable Outcome on Memory and Neurological Hallmarks
    Angel, Ariel
    Volkman, Rotem
    Royal, Tabitha Grace
    Offen, Daniel
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (03)
  • [32] New opportunities in the management and treatment of refractory hypercholesterolemia using in vivo CRISPR-mediated genome/base editing
    Srivastava, Rai Ajit K.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2023, 33 (12) : 2317 - 2325
  • [33] CRISPR-Cas9-Mediated Genome Editing Increases Lifespan and Improves Motor Deficits in a Huntington's Disease Mouse Model
    Ekman, Freja K.
    Ojala, David S.
    Adil, Maroof M.
    Lopez, Paola A.
    Schaffer, David, V
    Gaj, Thomas
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2019, 17 : 829 - 839
  • [34] Allele-specific gene editing for Huntington's disease mediated by a self-inactivating CRISPR/Cas9 system
    Vachey, G.
    Regio, S.
    Buron, J.
    Donat, T.
    Ouared, A.
    Stibolt, C.
    Kocher, J.
    Ferreira, A.
    Deglon, N.
    HUMAN GENE THERAPY, 2018, 29 (12) : A83 - A84
  • [35] Loss of function of DJ-1 triggered by Parkinson's disease-associated mutation is due to proteolytic resistance to caspase-6
    Giaime, E.
    Sunyach, C.
    Druon, C.
    Scarzello, S.
    Robert, G.
    Grosso, S.
    Auberger, P.
    Goldberg, M. S.
    Shen, J.
    Heutink, P.
    Pouyssegur, J.
    Pages, G.
    Checler, F.
    da Costa, C. Alves
    CELL DEATH AND DIFFERENTIATION, 2010, 17 (01): : 158 - 169
  • [36] Inhibition of tumour necrosis factor alpha in the R6/2 mouse model of Huntington's disease by etanercept treatment
    Pido-Lopez, Jeffrey
    Tanudjojo, Benedict
    Farag, Sahar
    Bondulich, Marie-Katrin
    Andre, Ralph
    Tabrizi, Sarah J.
    Bates, Gillian P.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [37] A Pilot Study Using Nabilone for Symptomatic Treatment in Huntington's Disease
    Curtis, Adrienne
    Mitchell, Ian
    Patel, Smitaa
    Ives, Natalie
    Rickards, Hugh
    MOVEMENT DISORDERS, 2009, 24 (15) : 2254 - 2259
  • [38] Inhibition of tumour necrosis factor alpha in the R6/2 mouse model of Huntington’s disease by etanercept treatment
    Jeffrey Pido-Lopez
    Benedict Tanudjojo
    Sahar Farag
    Marie-Katrin Bondulich
    Ralph Andre
    Sarah J. Tabrizi
    Gillian P. Bates
    Scientific Reports, 9
  • [39] Salsalate reverses metabolic disorders in a mouse model of non-alcoholic fatty liver disease through AMPK activation and caspase-6 activity inhibition
    Li, Jingjing
    Chen, Changmai
    Zhang, Wei
    Bi, Jing'ai
    Yang, Guang
    Li, Erguang
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2021, 128 (03) : 394 - 409
  • [40] CRISPR/Cas9 Gene Editing: A Novel Approach Towards Alzheimer's Disease Treatment
    Tripathi, Siddhant
    Sharma, Yashika
    Rane, Rajesh
    Kumar, Dileep
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2024, 23 (12) : 1405 - 1424
12345